- Home
- BCRX vs LEU Comparison
BCRX vs LEU Comparison
Compare BCRX & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- LEU
- Stock Information
- Founded
- BCRX 1986
- LEU 1998
- Country
- BCRX United States
- LEU United States
- Employees
- BCRX N/A
- LEU N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- BCRX Health Care
- LEU Industrials
- Exchange
- BCRX Nasdaq
- LEU Nasdaq
- Market Cap
- BCRX 1.7B
- LEU 1.6B
- IPO Year
- BCRX 1994
- LEU 1998
- Fundamental
- Price
- BCRX $10.09
- LEU $190.76
- Analyst Decision
- BCRX Buy
- LEU Strong Buy
- Analyst Count
- BCRX 8
- LEU 8
- Target Price
- BCRX $16.75
- LEU $154.57
- AVG Volume (30 Days)
- BCRX 3.5M
- LEU 1.6M
- Earning Date
- BCRX 08-04-2025
- LEU 08-05-2025
- Dividend Yield
- BCRX N/A
- LEU N/A
- EPS Growth
- BCRX N/A
- LEU 40.85
- EPS
- BCRX N/A
- LEU 6.39
- Revenue
- BCRX $503,485,000.00
- LEU $471,400,000.00
- Revenue This Year
- BCRX $39.04
- LEU $3.22
- Revenue Next Year
- BCRX $13.26
- LEU $9.91
- P/E Ratio
- BCRX N/A
- LEU $29.81
- Revenue Growth
- BCRX 41.67
- LEU 58.72
- 52 Week Low
- BCRX $5.92
- LEU $33.51
- 52 Week High
- BCRX $11.31
- LEU $211.31
- Technical
- Relative Strength Index (RSI)
- BCRX 43.54
- LEU 89.85
- Support Level
- BCRX $9.84
- LEU $152.16
- Resistance Level
- BCRX $10.47
- LEU $176.62
- Average True Range (ATR)
- BCRX 0.34
- LEU 11.29
- MACD
- BCRX -0.19
- LEU 3.26
- Stochastic Oscillator
- BCRX 8.16
- LEU 76.66
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.